| Literature DB >> 30310367 |
Dong Seop Jeong1, Woosik Han1, Young Tak Lee1, Wook Sung Kim1, Jinyoung Song2, I-Seok Kang2, Pyo Won Park1.
Abstract
BACKGROUND: This study aimed to review the long-term clinical outcomes and graft patency of coronary artery bypass grafting (CABG) using arterial grafts in patients with Kawasaki disease (KD) affecting the coronary artery.Entities:
Keywords: Coronary Artery Bypass Grafting; Graft; Kawasaki Disease
Mesh:
Year: 2018 PMID: 30310367 PMCID: PMC6179982 DOI: 10.3346/jkms.2018.33.e267
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Baseline patient characteristics
| Variables | All patients (n = 20)a | |
|---|---|---|
| Age at KD onset, yr, median (range) | 3 (0–7) | |
| Age at operation, yr, median (range) | 17.5 (2–42) | |
| Sex, female, No. (%) | 4 (20) | |
| Previous MI, No. (%) | 8 (40) | |
| Preoperative LVEF, %, mean | 55.84 ± 14.05 | |
| Low preoperative EF (< 0.40), No. (%) | 3 (15) | |
| Involved coronary lesions, including stenosis and aneurysms, No. (%) | ||
| Left main coronary artery | 4 (20) | |
| 1 vessel disease | 1 (5) | |
| 2 vessel disease | 10 (50) | |
| 3 vessel disease | 5 (25) | |
KD = Kawasaki disease, MI = myocardial infarction, LVEF = left ventricle ejection fraction, EF = ejection fraction.
aData acquired between January 2002 and June 2014.
Summarized data of the grafts used and the target vessels
| Variables | Value | |
|---|---|---|
| No. of grafts per patient, mean (range) | 1.7 ± 0.6 (1–3) | |
| No. of grafted target vessels per patient, mean (range) | 2.2 ± 1.1 (1–4) | |
| No. of total grafted target vessels | 44 | |
| No. of grafted LITA | 27 | |
| LAD | 17 | |
| D | 6 | |
| OM | 3 | |
| RI | 1 | |
| No. of grafted RITA | 13 | |
| RCA | 6 | |
| PDA | 2 | |
| OM | 2 | |
| D | 2 | |
| LAD | 1 | |
| No. of grafted GEA | 3 | |
| RCA | 2 | |
| LAD | 1 | |
| No. of grafted SVG | 1 | |
| OM | 1 | |
LITA = left internal thoracic artery, LAD = left anterior descending artery, D = diagonal branch, OM = obtuse marginal branch, RI = ramus intermedius branch, RITA = right internal thoracic artery, RCA = right coronary artery, PDA = posterior descending artery, GEA = gastroepiploic artery, SVG = saphenous vein graft.
Fig. 1Flow diagram of the outcomes of each graft.
LITA = left internal thoracic artery, RITA = right internal thoracic artery, RGEA = right gastroepiploic artery, SVG = saphenous vein graft, LAD = left anterior descending artery, OM = obtuse marginal branch, RCA = right coronary artery, PBA = percutaneous balloon angioplasty.
Fig. 2Freedom from coronary reintervention: online only.
TVR = target vessel revascularization.
Clinical outcomes of CABG
| Case number | Sex | Age, yr | Preoperative lesions | Surgical procedure | Off-pump | Graft patency | Patency follow-up, mon | Coronary reintervention |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 2 | LAD-A | LITA-LAD | X | P | 150 | PTRA on new LCX lesion |
| RCA-A | ||||||||
| 2 | M | 20 | LM (STO)-A | LITA-LAD | O | Not done | - | (-) |
| LAD (TO) | RITA(Y)-D1-D2 | |||||||
| 3 | M | 6 | LAD-A | LITA-LAD | X | P | 63 | (-) |
| RCA-A | ||||||||
| 4 | M | 16 | LAD (TO)-A | LITA-LAD | O | P | 47 | (-) |
| RCA-A | ||||||||
| 5 | M | 30 | LAD (TO)-A | LITA-D1 | O | P | 90 | (-) |
| LCX (95%) | RITA (Y)-LAD | |||||||
| SVG-OM | ||||||||
| 6 | M | 42 | LAD (95%) | LITA-OM | X | P | 56 | (-) |
| LCX (95%) | Small LITA (Y)-D | |||||||
| RI (TO) | GEA-distal LAD | |||||||
| RCA (95%) | LAD endarterectomy and angioplasty with SVG (6 cm) | |||||||
| 7 | M | 10 | LAD-A | GEA-RCA | O | Not done | - | (-) |
| RCA (TO)-A | ||||||||
| 8 | F | 14 | LAD-A | LITA-LAD | O | O: string-sign | 19 | PBA on LITA |
| RCA-A | ||||||||
| 9 | M | 5 | LAD (STO)-A | LITA-LAD | O | P | 83 | (-) |
| RCA-A | ||||||||
| 10 | F | 17 | LAD (TO) | LITA-D-LAD | O | Not done | - | (-) |
| LCX (SS)-A | RITA(Y)-OM-PDA | |||||||
| RCA (TO) | ||||||||
| 11 | M | 16 | LM-A | LITA-LAD | O | LITA:P | 27 | PBA on GEA |
| LAD (90%) | Small LITA (Y)-RI | Small LITA: O | ||||||
| LCX (90%) | GEA-RCA | GEA: 75% | ||||||
| RCA (90%)-A | ||||||||
| 12 | F | 30 | LAD (TO)-A | LITA-LAD | O | P | 16 | Redo CABG on new LCX lesion with RITA |
| LCX-A | ||||||||
| 13 | M | 23 | LAD (TO) | LITA-LAD | O | P | 35 | (-) |
| RCA (TO)-A | RITA-RCA | |||||||
| 14 | M | 28 | LAD (TO)-A | LITA-D2-LAD | O | P | 12 | (-) |
| Small LITA(Y)-D1 | ||||||||
| 15 | M | 18 | LAD (TO)-A | LITA-LAD | O | P | 7 | (-) |
| RCA (TO)-A | RITA-RCA | |||||||
| 16 | M | 9 | LM-A | LITA-LAD | X | LAD: P | 7 | (-) |
| LAD-A | Small LITA(Y)-OM | OM: O | ||||||
| LCX (TO) | RITA-RCA | RCA: P | ||||||
| RCA-A | ||||||||
| 17 | M | 12 | LAD (90%)-A | LITA-LAD | X | Not done | - | (-) |
| LCX (90%) | Small LITA(Y)-OM | |||||||
| RCA (80%)-A | RITA-RCA | |||||||
| 18 | M | 28 | LM-A | LITA-LAD | O | P | 20 | (-) |
| LAD (STO)-A | RITA-RCA | |||||||
| LCX-A | ||||||||
| RCA (TO) | ||||||||
| 19 | M | 38 | LM (STO) | LITA-D-LAD | O | P | 0 | (-) |
| LAD (TO)-A | RITA(Y)-OM-PDA | |||||||
| LCX (MO)-A | ||||||||
| RCA (TO)-A | ||||||||
| 20 | M | 39 | LAD (TO)-A | LITA-LAD | O | P | 0 | (-) |
| RI (60%) | RITA-RCA | |||||||
| LCX-A | ||||||||
| RCA (TO)-A |
M = male, F = female, LM = left main lesion, LAD = left anterior descending artery, D = diagonal branch, LCX = left circumflex artery, OM = obtuse marginal branch, RI = ramus intermedius branch, RCA = right coronary artery, PDA = posterior descending artery, STO = subtotal occlusion, TO = total occlusion, O = occluded, P = patent, PTRA = percutaneous transluminal rotablation, LITA = left internal thoracic artery, RITA = right internal thoracic artery, Y = y configuration anastomosis, SVG = saphenous vein graft, GEA = gastroepiploic artery, CABG = coronary artery bypass grafting, PBA = percutaneous balloon angioplasty.
Fig. 3Coronary angiography in a patient requiring repeat CABG. (A) Patent LITA graft to the LAD. (B) Newly detected occlusion of the left circumflex artery: online only.
CABG = coronary artery bypass grafting, LITA = left internal thoracic artery, LAD = left anterior descending artery, NG = nitroglycerin injection.